Double vaccine attack on malaria shows promise in early trial
NCT ID NCT05357560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different malaria vaccines—one targeting the blood stage and one the liver stage—alone and in combination. 107 healthy adults and infants in The Gambia received the vaccines to check safety and immune response. The goal is to see if combining them offers better protection against malaria.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (PLASMODIUM FALCIPARUM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical Research Council Unit, Fajara
Banjul, PO Box 273, The Gambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single shot of a genetically weakened malaria parasite train the body to fight off the real thing?
- Could a Liver-Stage malaria vaccine shield mothers and babies?
- Cancer drug could supercharge malaria treatment and beat resistance
- Smart wristbands may spot malaria before symptoms strike
- Malaria drug resistance confirmed in ethiopia: study raises alarm
- One shot to stop malaria? new injection tested in rwanda